Scanned it and will dig into deeper soon. A few questions though. What would be the price range of an Ovarian test and is your $15 profit based on any information coming from the company. What is the best data point out there that would allow for a reasonable expectation of adoption as a routine test. You run numbers on 50%. Is that really high or possibly even conservative.
Then is there a short version of IP issues to their technology and/or any others that have comparable technology under development.
FYI, use to trade and invest at times in SQNM quite a bit.
Then what's the deal on your JH comment and his leaving. really sourced, speculation or just wishful thinking. I'd say his departure would be a positive no matter what.